Madrigal

is a Pennsylvania-based biopharmaceutical company that researches and develops novel therapeutics for the treatment of non-alcoholic steatohepatitis disease...
Read more
Madrigal President & CEO: William Sibold

President & CEO

William Sibold

CEO Approval Rating

82/100

Annual Revenue
$720.5M
Employees
92
Funding
$737.2M

Madrigal Competitors

1Intercept
2Gilead
3Galectin
4Galmed Pharmaceuticals
5Cirius Therapeutics
6PhaseBio
7Esperion
8Attune
9PanOptica
10Acer

Trending Companies